Desiccated Thyroid

Desiccated thyroid, a natural thyroid hormone replacement derived from the thyroid glands of pigs, contains a mixture of levothyroxine (T4) and liothyronine (T3) and is primarily studied for its potential benefits in managing hypothyroidism. Researchers observed that while desiccated thyroid may not consistently outperform standard levothyroxine therapy, some patients, particularly those with persistent symptoms on levothyroxine alone, reported subjective improvements when using desiccated thyroid. Clinical evidence indicates that desiccated thyroid can lead to increased heart rate and may be preferred by a subset of symptomatic patients who do not respond adequately to levothyroxine. Current research continues to explore its efficacy and safety, highlighting the need for careful patient selection and consideration of individual responses to thyroid hormone therapies.

Desiccated thyroid, also known as natural desiccated thyroid (NDT) or Armour Thyroid, is a thyroid hormone replacement therapy derived from the dried thyroid glands of pigs. It is classified as a thyroid hormone and contains a combination of levothyroxine (T4) and liothyronine (T3), which are endogenous hormones produced by the human thyroid gland. Historically, NDT was a common treatment for hypothyroidism until synthetic levothyroxine became the standard. The primary physiological role of desiccated thyroid is to supplement or replace endogenous thyroid hormones in individuals with hypothyroidism. Researchers have found that NDT can be beneficial for patients who do not respond adequately to levothyroxine alone, as it provides both T4 and T3, potentially addressing symptoms more effectively in certain cases. The mechanism of action of desiccated thyroid involves binding to thyroid hormone receptors in the nucleus of cells, leading to the activation of gene transcription and subsequent protein synthesis. This cascade affects various metabolic processes, including basal metabolic rate and protein synthesis. Pharmacokinetically, the components of desiccated thyroid have different half-lives; levothyroxine has a longer half-life than liothyronine, which allows for once-daily dosing. The bioavailability of oral NDT is influenced by gastrointestinal absorption and first-pass metabolism. Clinically, desiccated thyroid is used primarily for the treatment of hypothyroidism, particularly in patients who do not achieve symptom relief with levothyroxine alone. Regulatory standing varies by region, with NDT being available by prescription in several countries, though it is less commonly prescribed than synthetic alternatives.

Desiccated thyroid acts on thyroid hormone receptors, primarily TRα and TRβ, which are nuclear receptors. Upon binding, it activates transcription of genes involved in metabolic regulation, impacting processes such as energy expenditure and protein synthesis.

Desiccated thyroid (DTE) acts primarily through the thyroid hormone receptors (TRs), which are nuclear receptors that regulate gene expression upon binding to thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3). This binding activates various signaling pathways, including the cAMP/PKA pathway and the MAPK pathway, leading to increased metabolic processes such as protein synthesis, glucose metabolism, and thermogenesis. The exact mechanism of action of DTE is not fully understood, particularly regarding the differential effects of T4 and T3 in various tissues.

Current evidence is limited regarding the long-term efficacy and safety of desiccated thyroid (DTE) compared to levothyroxine (LT4) and LT4+liothyronine (LT3) in diverse populations, particularly among those who are symptomatic despite LT4 therapy. Further research is needed through larger randomized controlled trials (RCTs) that focus on specific subgroups of hypothyroid patients, including those with varying etiologies and degrees of symptom severity, to clarify the potential benefits and optimal dosing of DTE. Additionally, studies investigating the long-term outcomes and quality of life in patients treated with DTE are essential to establish its role in modern hypothyroidism management.